NCT05896020View on ClinicalTrials.gov

A Study of SHR-A1811 in Subjects With Gynaecologic Oncology

PHASE2RecruitingINTERVENTIONAL

Enrollment

225

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

June 15, 2026

Study Completion Date

June 15, 2026

Conditions

Gynaecological Malignancies

Interventions

DRUG

SHR- A1811

Subjects with gynaecological malignancies

Trial Locations (1)

250012

RECRUITING

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY